Phospholipid-coated targeted microbubbles for ultrasound molecular imaging and therapy

Simone A.G. Langeveld, Bram Meijlink, Klazina Kooiman*

*Corresponding author for this work

Research output: Contribution to journalReview articlePopular

8 Citations (Scopus)


Phospholipid-coated microbubbles are ultrasound contrast agents that, when functionalized, adhere to specific biomarkers on cells. In this concise review, we highlight recent developments in strategies for targeting the microbubbles and their use for ultrasound molecular imaging (UMI) and therapy. Recently developed novel targeting strategies include magnetic functionalization, triple targeting, and the use of several new ligands. UMI is a powerful technique for studying disease progression, diagnostic imaging, and monitoring of therapeutic responses. Targeted microbubbles (tMBs) have been used for the treatment of cardiovascular diseases and cancer, with therapeutics either coadministered or loaded onto the tMBs. Regardless of which disease was treated, the use of tMBs always resulted in a better therapeutic outcome than non-tMBs when compared in vitro or in vivo.

Original languageEnglish
Pages (from-to)171-179
Number of pages9
JournalCurrent Opinion in Chemical Biology
Publication statusPublished - Aug 2021

Bibliographical note

Funding Information:
This work was supported by the Phospholipid Research Center [KKO-2017-057/1-1], Heidelberg, Germany; the Thoraxcenter of Erasmus MC; and Applied and Engineering Sciences TTW [Vidi-project 17543], part of NWO .

Publisher Copyright:
© 2021 The Authors


Dive into the research topics of 'Phospholipid-coated targeted microbubbles for ultrasound molecular imaging and therapy'. Together they form a unique fingerprint.

Cite this